Redcliffe Lifetech has raised $103M across 1 funding round, plus 1 undated round. The company is valued at $150M.
LeapFrog Investments backs Redcliffe Labs, saying it is committed to supporting the company as it expands access to diagnostics for emerging consumers across India, and has worked with it to execute and integrate two strategic acquisitions since investing.
1 funding round, the latest highlighted.
Redcliffe Lifetech was founded in 2017, India.
No date is disclosed for this round.
No filing has been made.
1 dated round, newest first.
LeapFrog InvestmentsLEADIIFULEADHHealthquadSSchrodersLLC NuevaGGrowth Spark VenturesCChiratae VenturesAAlkemi Venture PartnersThe closest healthcare peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Redcliffe Lifetech is a private company; its shares do not trade on a public exchange.
The last valuation is $150M.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
